• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Urokinase-type plasminogen activator as a predictor for lymph nodes metastasis of uterine cervical cancer].

作者信息

Fujishiro S, Kobayashi H, Terao T

机构信息

Department of Obstetrics and Gynecology, Hamamatsu University School of Medicine.

出版信息

Nihon Sanka Fujinka Gakkai Zasshi. 1994 Feb;46(2):129-36.

PMID:8126385
Abstract

The present study was undertaken to assess the role of tumor infiltrating lymphocytes and polymorphonuclear leukocyte-derived human leukocyte elastase (HLE) as an inactivator of urokinase-type plasminogen activator (uPA) activity. We have investigated the localization of pro-uPA/uPA and HLE immunohistochemically and quantitated in paraffin-embedded formalin-fixed uterine cervical cancer tissue sections (stage II) in 13 patients with positive lymph-nodes metastasis and in 16 cases with node-negative. The invasively growing and metastasizing tumor cells consistently contained uPA enzyme activity. When investigated immunohistochemically with antibody to uPA, different parts of individual tumors showed a pronounced heterogeneity in staining intensity. Strong staining was found in the areas with invasive growth and degradation of surrounding normal tissue. A statistically significant higher node-positive rate was observed in patients having tumors with strong uPA stainings than in those with weak stainings. On the other hand, inflammatory cells such as polymorphonuclear cells were located in aggregates or diffusely spread within tumor stromal tissue. The inflammatory reaction seemed to be most intense at the border between the surrounding normal stromas and the tumor tissue. These cells produced and secreted HLE. A statistically significant higher node-positive rate was observed in patients having tumors with weak HLE stainings than in those with strong stainings. Thus, uPA and HLE staining intensities in tissue specimens appear to be independent predictors of increasing and decreasing risk for node-positive, respectively, suggesting that HLE may act as a defence against tumor cell invasion and metastasis.

摘要

相似文献

1
[Urokinase-type plasminogen activator as a predictor for lymph nodes metastasis of uterine cervical cancer].
Nihon Sanka Fujinka Gakkai Zasshi. 1994 Feb;46(2):129-36.
2
Impact of urokinase-type plasminogen activator and its inhibitor type 1 on prognosis in cervical cancer of the uterus.尿激酶型纤溶酶原激活剂及其1型抑制剂对子宫颈癌预后的影响。
Cancer Res. 1994 Dec 15;54(24):6539-48.
3
Multimarker phenotype predicts adverse survival in patients with lymph node-negative colorectal cancer.多标志物表型可预测淋巴结阴性结直肠癌患者的不良生存情况。
Cancer. 2008 Feb 1;112(3):495-502. doi: 10.1002/cncr.23208.
4
Biochemical markers as a predictor for lymph-node involvement in patients with cervical-cancer of the uterus.生化标志物作为子宫颈癌患者淋巴结受累的预测指标。
Int J Oncol. 1994 May;4(5):1053-9. doi: 10.3892/ijo.4.5.1053.
5
The urokinase system of plasminogen activation and prognosis in 2780 breast cancer patients.2780例乳腺癌患者纤溶酶原激活物的尿激酶系统与预后
Cancer Res. 2000 Feb 1;60(3):636-43.
6
[Expression and significance of the urokinase-type plasminogen activator and its inhibitors in squamous cell carcinoma of human larynx].[尿激酶型纤溶酶原激活剂及其抑制剂在人喉鳞状细胞癌中的表达及意义]
Zhonghua Er Bi Yan Hou Ke Za Zhi. 2003 Feb;38(1):39-42.
7
Tumour-associated fibrinolysis: the prognostic relevance of plasminogen activators uPA and tPA in human breast cancer.肿瘤相关纤维蛋白溶解:纤溶酶原激活剂uPA和tPA在人类乳腺癌中的预后相关性
Blood Coagul Fibrinolysis. 1990 Dec;1(6):695-702.
8
Prognostic impact of stromal cell-derived urokinase-type plasminogen activator in gastric carcinoma.基质细胞衍生的尿激酶型纤溶酶原激活剂在胃癌中的预后影响。
Cancer. 1999 Mar 1;85(5):1033-8.
9
[Urokinase-type plasminogen activator (uPA), uPA receptor (uPA-R) and inhibitors (PA I -1) expression in hepatocellular carcinoma in relation to cancer invasion/metastasis and prognosis].[尿激酶型纤溶酶原激活物(uPA)、uPA受体(uPA-R)及抑制剂(PAI-1)在肝细胞癌中的表达与肿瘤侵袭/转移及预后的关系]
Zhonghua Zhong Liu Za Zhi. 1998 Jan;20(1):57-9.
10
Evaluation of urokinase plasminogen activator and its receptor in different grades of human prostate cancer.尿激酶型纤溶酶原激活剂及其受体在不同分级的人类前列腺癌中的评估
Hum Pathol. 2006 Nov;37(11):1442-51. doi: 10.1016/j.humpath.2006.05.002. Epub 2006 Jul 26.

引用本文的文献

1
Prostaglandin E2 receptor 3 (EP3) signaling promotes migration of cervical cancer via urokinase-type plasminogen activator receptor (uPAR).前列腺素 E2 受体 3 (EP3) 信号通过尿激酶型纤溶酶原激活物受体 (uPAR) 促进宫颈癌的迁移。
J Cancer Res Clin Oncol. 2020 Sep;146(9):2189-2203. doi: 10.1007/s00432-020-03272-0. Epub 2020 Jun 1.